EWEdwards Lifesciences Corp

NYSE edwards.com


$ 70.64 $ -0.94 (-1.31 %)    

Friday, 23-Aug-2024 14:33:38 EDT
QQQ $ 478.96 $ 0.19 (0.04 %)
DIA $ 410.87 $ 1.64 (0.4 %)
SPY $ 560.75 $ 1.22 (0.22 %)
TLT $ 98.30 $ 0.11 (0.11 %)
GLD $ 232.03 $ 2.66 (1.16 %)
$ 71.3
$ 71.58
$ 70.62 x 100
$ 70.65 x 100
$ 70.28 - $ 71.80
$ 58.93 - $ 96.12
5,022,471
na
42.95B
$ 1.18
$ 29.16
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 07-31-2024 06-30-2024 10-Q
2 04-29-2024 03-31-2024 10-Q
3 02-12-2024 12-31-2023 10-K
4 10-27-2023 09-30-2023 10-Q
5 07-28-2023 06-30-2023 10-Q
6 04-28-2023 03-31-2023 10-Q
7 02-13-2023 12-31-2022 10-K
8 10-28-2022 09-30-2022 10-Q
9 07-29-2022 06-30-2022 10-Q
10 04-28-2022 03-31-2022 10-Q
11 02-14-2022 12-31-2021 10-K
12 10-29-2021 09-30-2021 10-Q
13 07-30-2021 06-30-2021 10-Q
14 04-28-2021 03-31-2021 10-Q
15 02-12-2021 12-31-2020 10-K
16 10-26-2020 09-30-2020 10-Q
17 07-27-2020 06-30-2020 10-Q
18 04-28-2020 03-31-2020 10-Q
19 02-14-2020 12-31-2019 10-K
20 10-25-2019 09-30-2019 10-Q
21 07-26-2019 06-30-2019 10-Q
22 04-26-2019 03-31-2019 10-Q
23 02-15-2019 12-31-2018 10-K
24 10-26-2018 09-30-2018 10-Q
25 07-27-2018 06-30-2018 10-Q
26 04-27-2018 03-31-2018 10-Q
27 02-16-2018 12-31-2017 10-K
28 10-27-2017 09-30-2017 10-Q
29 07-28-2017 06-30-2017 10-Q
30 04-28-2017 03-31-2017 10-Q
31 02-17-2017 12-31-2016 10-K
32 10-28-2016 09-30-2016 10-Q
33 07-29-2016 06-30-2016 10-Q
34 04-29-2016 03-31-2016 10-Q
35 02-19-2016 12-31-2015 10-K
36 10-29-2015 09-30-2015 10-Q
37 07-29-2015 06-30-2015 10-Q
38 04-29-2015 03-31-2015 10-Q
39 02-20-2015 12-31-2014 10-K
40 10-31-2014 09-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 jim-cramer-says-this-home-improvement-chain-is-a-buy-ahead-of-fed-rate-cut-cycle-i-would-pick-some-up-tomorrow

Jim Cramer recommends buying Blackstone Inc. (BX) due to its strong companies and expects Lowe's (LOW) stock to benefit fro...

 wolfe-research-upgrades-edwards-lifesciences-to-peer-perform

Wolfe Research analyst Mike Polark upgrades Edwards Lifesciences (NYSE:EW) from Underperform to Peer Perform.

 ford-stellantis-and-dell-are-among-top-12-large-cap-losers-last-week-july-21-july-27-are-the-others-in-your-portfolio

Top 10 worst performers last week: EW (-28.05%), F (-19.12%), STM (-17.60%), TER (-16.25%), MBLY (-14.61%), STLA (-13.07%), VRT...

 barclays-maintains-overweight-on-edwards-lifesciences-lowers-price-target-to-90

Barclays analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Overweight and lowers the price target from $10...

 goldman-sachs-maintains-buy-on-edwards-lifesciences-lowers-price-target-to-91

Goldman Sachs analyst David Roman maintains Edwards Lifesciences (NYSE:EW) with a Buy and lowers the price target from $107 ...

 td-cowen-downgrades-edwards-lifesciences-to-hold-lowers-price-target-to-70

TD Cowen analyst Joshua Jennings downgrades Edwards Lifesciences (NYSE:EW) from Buy to Hold and lowers the price target from...

 edwards-lifesciences-stock-tumbles-highlights-slowdown-in-tavr-business

Edwards Lifesciences reported Q2 results, sales increased 7% to $1.632B, TAVR sales grew 5%, company to acquire JenaValve and E...

 wells-fargo-maintains-overweight-on-edwards-lifesciences-lowers-price-target-to-90

Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and lowers the price target f...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION